The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Periop-01: A randomized controlled trial of extended perioperative tinzaparin to improve disease-free survival in patients with resectable colorectal cancer.
 
Rebecca Ann C Auer
Research Funding - Leo Pharma (Inst)
 
Paul Jack Karanicolas
No Relationships to Disclose
 
Michael Ott
Consulting or Advisory Role - Johnson & Johnson (Inst)
 
Muriel Brackstone
No Relationships to Disclose
 
Shady Ashamalla
No Relationships to Disclose
 
Timothy R. Asmis
No Relationships to Disclose
 
Marylise Boutros
Honoraria - Johnson & Johnson
 
Antonio Caycedo Marulanda
Honoraria - Johnson & Johnson
Speakers' Bureau - Applied medical; Johnson & Johnson; Minogue Medical
 
Shiva Jayaraman
No Relationships to Disclose
 
Derek J. Jonker
No Relationships to Disclose
 
Husein Moloo
No Relationships to Disclose
 
Sunil Patel
No Relationships to Disclose
 
Silvana Spadafora
No Relationships to Disclose
 
Steven MacLellan
No Relationships to Disclose
 
Ranjeeta Mallick
No Relationships to Disclose
 
Peter Stotland
No Relationships to Disclose
 
Vicky Tagalakis
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer (Inst); Sanofi (Inst)
Speakers' Bureau - Bristol-Myers Squibb/Pfizer (Inst)
 
Daniel C. Trottier
No Relationships to Disclose
 
Joel Weaver
No Relationships to Disclose
 
Marc Carrier
Honoraria - Bayer (Inst); Bristol-Myers Squibb (Inst); Leo Pharma (Inst); Pfizer (Inst); Sanofi (Inst)
Consulting or Advisory Role - BMS Brazil (Inst); Sanofi (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Leo Pharma (Inst); Pfizer (Inst)